Demographics and the Cost of Pharmaceuticals in a Private Third-Party Prescription Program
نویسندگان
چکیده
منابع مشابه
Cost-shifting among rural Montana independent community pharmacies
Downey, Kyle A., MS Pharmacy Administration, June 1999 Cost-Shifting Among Rural Montana Independent Community Pharmacies (65 pp.) Director: Timothy P. Stratton, Ph.D., R.Ph. Cost-shifting is a familiar term within the health care community and is commonly associated with hospitals. Many other health care providers, including pharmacists, have been affected by the practice. With the number of p...
متن کاملTesting for Asymmetric Information in Automobile Insurance Market an Iranian Insurance Company
The presence of asymmetric information is an important source of efficiency loss for insurance companies and could reduce profitability. In this paper, we test the conditional independence of coverage choice and risk, where “conditional” means conditional on all variables observed by the insurer. We use two parametric methods: a pair of probits and a bivariate probit model. The data includes al...
متن کاملCost of atopic dermatitis and eczema in the United States.
BACKGROUND Atopic dermatitis/eczema (AD/E) is a common disease. Few studies have attempted to quantify the cost to third-party payers. OBJECTIVE Our purpose was to identify the annual cost of medical services and prescription drugs for the treatment of AD/E to private insurance and Medicaid payers in the United States. METHODS We used a retrospective study design employing claims data from ...
متن کاملEnsuring Access to Affordable Drug Coverage in Medicare
The long-awaited outpatient prescription drug benefit in Medicare began January 2006. Despite its importance, the drug benefit is controversial. Instead of paying directly for prescriptions, the program will operate through competing private plans. Although it is too early to assess the full impact of Part D on beneficiaries, health plans and providers, employers, and taxpayers, we can discuss ...
متن کاملClinical points of intravenous pantoprazole consumption in Cardiac ICU
Background: Proton pump inhibitors (PPIs) are the most common medicine for the treatment and prophylaxis of acid peptic conditions. The inappropriate use of the PPIs mainly intravenous form of Pantoprazole may lead to excessive cost and unexpected adverse effect. The purpose of our study was to evaluation the use of intravenous Pantoprazole in international heart center in north of Iran. Meth...
متن کامل